(NASDAQ: PRQR) Proqr Therapeutics Nv's forecast annual revenue growth rate of 18.65% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.5%, and while it is forecast to beat the US market's average forecast revenue growth rate of 10.08%.
Proqr Therapeutics Nv's revenue in 2024 is $10,353,260.On average, 3 Wall Street analysts forecast PRQR's revenue for 2024 to be $1,625,139,330, with the lowest PRQR revenue forecast at $610,159,440, and the highest PRQR revenue forecast at $2,440,637,760. On average, 2 Wall Street analysts forecast PRQR's revenue for 2025 to be $2,238,064,826, with the lowest PRQR revenue forecast at $699,649,491, and the highest PRQR revenue forecast at $3,776,480,161.
In 2026, PRQR is forecast to generate $1,097,473,446 in revenue, with the lowest revenue forecast at $805,410,461 and the highest revenue forecast at $1,389,536,431.